Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Wroclaw Medical University
With
Wrocław University of Science and Technology
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
diagnosis of primary open angle glaucoma
trabecular meshwork visible in gonioscopy
medicated IOP of ≥ 15 mmHg and ≤ 35 mmHg
taking 1 to 5 IOP-lowering medications
area of healthy, free and mobile conjunctiva in the target quadrant (superior-nasal)
signed inform consent
You may not be if
angle closure glaucoma
secondary open angle glaucoma
previous glaucoma shunt/valve in the target quadrant
presence of conjunctival scarring, prior conjunctival surgery or other conjunctival pathologies (e.g., pterygium) in the target quadrant
active inflammation (e.g., blepharitis, conjunctivitis, keratitis, uveitis)
active iris neovascularization or neovascularization of the iris within 6 months of the surgical date
anterior chamber intraocular lens
presence of intraocular silicone oil
vitreous present in the anterior chamber
impaired episcleral venous drainage (e.g., Sturge-Weber or nanophthalmos or other evidence of elevated venous pressure)
known or suspected allergy or sensitivity to drugs required for the surgical procedure or any of the device components (e.g., porcine products or glutaraldehyde)
history of dermatologic keloid formation
previous photorefractive keratectomy
Clareo Health | Efficacy and Safety of XEN® Gel Stent and Post-operative Management in Patients With Open Angle Glaucoma
